As compared to both obese and non-obese groups, NAFLD patients had a considerable increase in tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), and lower adiponectin levels [36]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.